LONDON, UK: Allergy Therapeutics announced the appointment of Cheryl MacDiarmid as a Non-Executive Director of the Company, with effect from 27 October 2021. Upon appointment Cheryl will also become a member of the Audit Committee. Cheryl MacDiarmid has more than 25 years’ experience in commercial roles within the global pharmaceuticals sector. She brings significant marketing,…